Rift Valley fever virus (RVFV; family Bunyaviridae) is a clinically important, mosquito-borne pathogen of both livestock and humans, which is found mainly in sub-Saharan Africa and the Arabian Peninsula. RVFV has a trisegmented single-stranded RNA (ssRNA) genome. The L and M segments are negative sense and encode the L protein (viral polymerase) on the L segment and the virion glycoproteins Gn and Gc as well as two other proteins, NSm and 78K, on the M segment. The S segment uses an ambisense coding strategy to express the nucleocapsid protein, N, and the nonstructural protein, NSs. Both the NSs and NSm proteins are dispensable for virus growth in tissue culture. Using reverse genetics, we generated a recombinant virus, designated r2segMP12, containing a two-segmented genome in which the NSs coding sequence was replaced with that for the Gn and Gc precursor. Thus, r2segMP12 lacks an M segment, and although it was attenuated in comparison to the three-segmented parental virus in both mammalian and insect cell cultures, it was genetically stable over multiple passages. We further show that the virus can stably maintain an M-like RNA segment encoding the enhanced green fluorescent protein gene. The implications of these findings for RVFV genome packaging and the potential to develop multivalent live-attenuated vaccines are discussed.
Rift Valley fever virus (RVFV) is an emerging pathogen capable of causing serious epidemics among livestock and humans. Originally isolated in sub-Saharan Africa, the virus has spread northward to Egypt and the Arabian peninsula (43) and has resulted in huge economic losses of domesticated animals as well as more than a thousand human deaths. In ruminants, particularly sheep and cattle, RVFV disease is characterized by fetal deformities, abortion, and high rates of mortality among young animals (44) . In humans, the disease can progress from self-limiting febrile illness to hemorrhagic fever, encephalitis, or retinal vasculitis. RVFV is predominantly transmitted by mosquitoes, and the virus has been isolated from more than 40 species in nature, while under laboratory conditions many different arthropods are capable of transmitting the virus (reference 46 and references therein). In an era of climate change, the spread of competent insect vectors into "virgin" territories is a major public health concern, making RVF a potential worldwide human, animal, and economic threat (12) .
RVFV is a member of the Phlebovirus genus in the Bunyaviridae family and contains a tripartite single-stranded RNA (ssRNA) genome comprising two negative-sense and one ambisense segment (reviewed in reference 7). The large (L) segment (approximately 6.4 kb) codes for the viral RNA-dependent RNA polymerase (L protein). The medium (M) segment (approximately 3.8 kb) encodes four proteins in a single open reading frame (ORF): the precursor to the virion envelope glycoproteins Gn and Gc and two other proteins called NSm (or NSm2) and 78K (or NSm1), depending on which of five methionine codons that translation initiates from (18, 50) . The small (S) segment (approximately 1.7 kb) is ambisense and encodes the nucleocapsid protein, N, in the negative sense and the nonstructural protein NSs in the positive sense of the genomic RNA; both proteins are translated from specific subgenomic mRNAs (30) . Previous studies have shown that NSs and NSm are dispensable for virus growth in tissue culture and that NSs and NSm function as virulence factors and determinants of mammalian host pathogenesis (2-4, 21, 25, 26, 51) . Each genome segment comprises a coding sequence flanked by untranslated regions (UTR) at the 3Ј and 5Ј ends. In addition, the two ORFs in the ambisense S segment are separated by a cytosine-rich intergenic region. The very terminal 8 residues at both ends of all three genome segments are conserved in sequence and are invertedly complementary, permitting the ends of the RNAs to base-pair with a panhandle structure (28) . The remainder of the UTRs are variable in length and comprise sequences unique for each segment. The UTRs contain the promoters for transcription and replication and differ in their ability to regulate RNA synthesis (17) . The UTRs probably also contain signals for recognition by N protein for encapsidation of the genome to form ribonucleoprotein complexes (RNP), which are the functional templates for transcription and replication by the L protein, and signals for the packaging of the RNPs into virions (17, 27, 33) .
Reverse genetic systems that allow recovery of infectious virus from cloned cDNA copies of the RVFV genomic RNA segments have been developed by several groups (1, 19, 29) based on the methodology originally established for the prototype bunyavirus, Bunyamwera virus (BUNV) (8) . We exploited this technology to generate a recombinant RVFV, derived from the MP12 candidate vaccine strain of RVFV (11) , that contains a two-segmented rather than a three-segmented genome. The coding sequence for the Gn-Gc precursor was inserted into the S segment in place of the NSs gene, creating a hybrid genomic S segment that maintained its ambisense coding strategy. Thus, the recombinant virus, designated r2segMP12, has a coding strategy reminiscent of that of the arenaviruses. We also show that a chimeric RNA encoding the enhanced green fluorescent protein (eGFP) gene, in the negative sense, flanked by the M segment UTRs, can be introduced into r2segMP12 and stably maintained upon repeated passage. We discuss the implications of these findings for understanding RVFV genome packaging and for developing liveattenuated vaccines.
MATERIALS AND METHODS

Cells and viruses.
Vero-E6 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS). BSR-T7/5 cells (9), which stably express T7 RNA polymerase, were provided by K. K. Conzelmann (Max-von-Pettenkofer Institut, Munich, Germany) and were grown in Glasgow minimal essential medium (GMEM) supplemented with 10% FCS and 1 mg/ml G418. BHK-21 cells were grown in GMEM supplemented with 10% tryptose phosphate broth (TPB) and 10% newborn calf serum (NCS). All mammalian cell lines were grown at 37°C with 5% CO 2 unless otherwise stated. The Aedes albopictus-derived cell line C6/36 was maintained in Leibovitz's L-15 medium supplemented with 10% FCS and 8% TPB. These cells were incubated at 28°C in the absence of CO 2 .
All experiments with infectious virus were conducted under biosafety level 3 (BSL-3) conditions. Stocks of recombinant viruses were grown in BHK-21 cells at 33°C by infecting at a multiplicity of infection (MOI) of 0.001 and harvesting the culture medium at 72 h postinfection (p.i.). For serial passage of viruses at low multiplicity, infected BHK-21 cells were grown at 33°C in medium supplemented with 2% NCS until a marked cytopathic effect (CPE) was observed; the supernatant was clarified, and an aliquot was used to inoculate fresh BHK-21 cell monolayers.
Plasmids. Plasmids for the recovery of RVFV have been described previously (1) and were provided by A. Billecocq and M. Bouloy, Pasteur Institute, Paris, France. pTM1-L and pTM1-N contain the RVFV MP12 L and N ORFs under the control of the T7 promoter and encephalomyocarditis virus internal ribosome entry site sequence; pTVT7-GS, pTVT7-GM, and pTVT7-GL contain full-length cDNAs of the RVFV strain MP12 antigenome segments flanked by the T7 promoter and hepatitis delta ribozyme sequences. Plasmid pTVT7-GSdelNSs:Gn/Gc contains the Gn-Gc coding region (nucleotides [nt] 411 to 3614 of the RVFV M segment) in place of the NSs gene (see Fig. 2A ), and pTVT7-GM: delNSm was generated by excision PCR using pTVT7-GM as a template to delete the NSm coding sequence. The construct pTVT7-GMdelMORF:eGFP was derived from pTVT7-GM by inserting the eGFP ORF exactly in place of the M polyprotein coding sequence, maintaining the complete M segment untranslated regions. Details of molecular cloning, primers, and PCRs are given in the supplemental material.
Generation of recombinant viruses from cDNA. Recombinant RVFV were generated by transfecting 7 ϫ 10 5 BSR-T7/5 cells with 0.5 g each pTM1-L and pTM1-N and 1 g each pTVT7-based plasmid expressing the viral genomic segments as appropriate, using 3 l Lipofectamine 2000 (Invitrogen) per g of DNA. After 5 to 7 days, when extensive CPE was observed, the virus-containing supernatants were collected, clarified by low-speed centrifugation, and stored at Ϫ80°C.
Virus titration by plaque assay. BHK-21 cells were infected with serial dilutions of virus and incubated under an overlay consisting of GMEM supplemented with 2% NCS and 0.6% Avicel (FMC BioPolymer) at 37°C for 4 days. Cell monolayers were fixed with 4% paraformaldehyde, and plaques were visualized by Giemsa staining.
Virus growth curves. BHK-21, Vero E6, or A. albopictus C6/36 cells were infected at an MOI of 1. One hour postinfection, the inoculum was removed and the cells were washed with phosphate-buffered saline (PBS) to remove unattached viruses. At the indicated time points, the supernatant fluid was collected and virus titrated by plaque assay on BHK-21 cells.
Western blotting. Cells were infected as described above, and at various time points after infection, cell lysates were prepared by the addition of 300 l lysis buffer (100 mM Tris-HCl [pH 6.8], 4% SDS, 20% glycerol, 200 mM dithiothreitol
[DTT], 0.2% bromophenol blue, and 25 U/ml Benzonase [Novagen]), and proteins were separated on a 4 to 12% SDS-PAGE gel (Invitrogen). Proteins were transferred to a Hybond-C Extra membrane (Amersham), and the membrane was blocked by incubating it in saturation buffer (PBS containing 5% dry milk and 0.1% Tween 20) for 1 h. The membrane was reacted with anti-N and anti-NSs polyclonal antibodies raised in rabbits, an anti-Gn antibody (ProSci, Inc.; catalog no. 4519), or an anti-tubulin monoclonal antibody (Sigma). This was followed by incubation with either horseradish peroxidase (HRP)-labeled antirabbit (Cell Signaling Technology) or anti-mouse (Sigma) antibodies. Visualization of detected proteins was achieved using SuperSignal WestPico chemiluminescent substrate (Pierce) followed by exposure to X-ray film or a Fujifilm LAS-1000 luminescent image analyzer for quantification.
Northern blotting and RT-PCR. BHK-21 cells were infected at an MOI of 1, and total cellular RNA was extracted at 48 h p.i. using TRIzol reagent (Invitrogen). Four micrograms of RNA was electrophoresed through a 1.2% agarose gel in TAE buffer (35) and then transferred to a positively charged nylon membrane (Roche). The membrane was hybridized with digoxigenin-labeled RNA probes complementary to genome sense (Ϫ) or anti-genome sense (ϩ) sequences representing L, Gn, NSm, N, NSs, or eGFP protein coding sequences (150 ng of each probe); detection was carried out using a DIG Northern starter kit (Roche). For reverse transcription-PCR (RT-PCR), 1 g of total cellular RNA was mixed with a segment-specific oligonucleotide, 0.5 mM 4ϫ dNTP mix (Promega), 40 U rRNasin (Promega), and 200 U Moloney murine leukemia virus (M-MLV) reverse transcriptase (Promega) and incubated at 42°C for 3 h. The resulting cDNA was used in PCRs with primers as described in Results and the supplemental material, and the products were visualized by agarose gel electrophoresis.
RESULTS
Rescue of recombinant Rift Valley fever viruses.
It was previously reported that the NSs gene was not essential for the growth of RVFV in mammalian cell culture systems and small animal models (3, 29, 36, 47) and that a reporter gene could be expressed in place of NSs (29) . Therefore, we investigated the possibility of expressing the RVFV glycoprotein genes in place of NSs, thereby creating a virus with a coding strategy akin to that of the two-segmented arenaviruses in which the S segment encodes N and the glycoprotein precursor in an ambisense manner (10) . We attempted to insert the complete M segment polyprotein coding sequence or the sequence encoding the Gn-Gc precursor (translation of the precursor is initiated at the fourth methionine codon in the M-segment ORF [18] ) into pTVT7-GS in place of the NSs gene. Despite repeated attempts, involving different recipient Escherichia coli strains, we were unable to clone the full-length polyprotein coding sequence into pTVT7-GS. However, we successfully obtained a construct containing the Gn-Gc sequence, which was designated pTVT7-GSdelNSs:Gn/Gc. This plasmid was used in the reverse genetics protocol together with the L-segment plasmid pTVT7-GL and the pTM1-derived plasmids expressing the viral N and L proteins. We set up two control rescue experiments, first to generate parental MP12 virus (rMP12) and second to generate an NSm/NSs doubly deleted three-segmented virus with the eGFP gene in place of NSs, to mimic the virus created by Bird et al. (3), designated rMP12-delNSs: eGFP-delNSm. Viruses were recovered from all rescue experiments at the first attempt. Stocks of each virus were prepared, and the presumptive two-segmented virus, designated r2segMP12, grew to a lower titer (1.6 ϫ 10 7 PFU/ml) than the parental strain, rMP12 (1.8 ϫ 10 8 PFU/ml). The three-segmented NSm/NSs doubly deleted virus, rMP12-delNSs:eGFPdelNSm, also grew to a lower titer than the parental strain produced by r2segMP12 were smaller than those of either the parental rMP12 strain or the doubly deleted three-segmented virus rMP12-delNSs:eGFP-delNSm ( Fig. 1) , consistent with the slower growth kinetics observed in the time course experiments (see below). Confirmation of the two-segmented virus genome. We used a specific RT-PCR approach to confirm the structure of the S-genome segment in r2segMP12; the S segment of rMP12 was examined as a control (Fig. 2 ). Infected-cell RNA was reverse transcribed using a primer specific for the 3Ј end of the S segment, and then PCRs were performed using primers designed to anneal to the glycoprotein ORF (primer ␣), the 3Ј end of the N ORF (primer ␤), or the S-segment 3Ј UTR (primer ). When using primers ␤ and and rMP12-derived S-segment cDNA as the template, a PCR product of about 1 kb that corresponds to the expected size (1,041 nt) for the viral 3Ј UTR, NSs ORF, and intergenic region was produced (Fig. 2B) . In contrast, the r2segMP12-derived S-segment cDNA gave a product of about 3.4 kb (Fig. 2B) . When primer set ␣ and ␤ was used on the rMP12-derived S-segment cDNA, no product was detected. However, the r2segMP12-derived S-segment cDNA gave a product of about 3 kb (Fig. 2C) . The first primer set confirmed that an insertion of the correct size corresponding to the Gn-Gc precursor sequence was present. The second primer set demonstrates that the Gn-Gc coding sequence was inserted in place of the NSs ORF. Furthermore, nucleotide sequence analyses of RT-PCR products covering the complete hybrid S segment confirmed the expected sequence and that no mutations had occurred in the generation of r2segMP12.
Analysis of viral RNA from infected cells. Northern blot analysis of total cellular RNA from infected BHK-21 cells showed the differing genomic organization of the parental rMP12 and two-segmented r2segMP12 viruses. Digoxigeninlabeled probes were used to detect viral genomic [probes designated (Ϫ)] or viral anti-genomic [probes designated (ϩ)] RNA species (Fig. 3 ). In the sample from rMP12-infected cells, the N(Ϫ) probe detected an RNA of approximately 1.7 kb, the size expected of the native S segment (actually 1,690 nt). However, RNA from r2segMP12-infected cells gave a band of approximately 4.1 kb (Fig. 3A) with the same probe. The Gn(Ϫ) and Gn(ϩ) probes also detected a similarly sized RNA species in the r2segMP12 sample ( Fig. 3B and C) . This RNA species is the size expected for the engineered S segment in the r2segMP12 virus (actually 4,115 nt). The Gn(ϩ) probe hybridized with a slightly smaller RNA (approximately 3.3 kb) in the r2segMP12-infected intracellular RNA (Fig. 3C) , and this band would correspond to a subgenomic mRNA encoding the Gn-Gc precursor produced by the ambisense S segment of r2segMP12. The Gn probes detected only a single RNA species in rMP12-infected cell RNA corresponding to the 3,885-nt M segment. The genomic L-segment RNA (6,404 nt) was detected with the L(Ϫ) probe in both the rMP12 and r2segMP12 intracellular RNA samples (Fig. 3D) .
Hybrization with the N(ϩ) probe showed that the subgenomic N mRNA (approximately 850 nt) was produced efficiently in cells infected with both rMP12 and r2segMP12 (Fig.  3E ). Using the NSs(Ϫ) probe, no RNA corresponding to the subgenomic NSs mRNA was detected in the r2segMP12-infected cell sample, whereas both full-length S-segment RNA and NSs mRNA were clearly visible in rMP12-infected cell RNA samples (Fig. 3F) . These results confirm the RNA genome structure of r2segMP12 and that the engineered S segment is transcribed to yield subgenomic mRNAs for the N and Gn-Gc precursor proteins.
Growth properties of rMP12, r2segMP12, and rMP12-delNSs:eGFP-delNSm in cell culture. The growth properties of recombinant viruses were compared in BHK-21, Vero E6, and A. albopictus C6/36 cells infected at an MOI of 1. At different times postinfection, the tissue culture supernatants were harvested and virus titers determined by plaque assay in BHK-21 cells. The cell monolayers were also harvested to monitor the expression of the N and NSs proteins. Both rMP12 and rMP12-delNSs:eGFP-delNSm exhibited similar growth properties in mammalian cell lines, with peak titers of 1.85 ϫ 10 8 and 1.3 ϫ 10 8 PFU/ml in BHK-21 cells and 6 ϫ 10 7 and 3.75 ϫ 10 7 PFU/ml in Vero E6 cells, respectively. However, in C6/36 cells, rMP12 grew to a higher titer (1.25 ϫ 10 9 PFU/ml) than rMP12-delNSs:eGFP-delNSm (2 ϫ 10 8 PFU/ml). In all cell lines, the two-segmented r2segMP12 virus was attenuated compared to both rMP12-delNSs:eGFP-delNSm and rMP12, achieving titers of 2.4 ϫ 10 5 and 2.9 ϫ 10 5 PFU/ml in Vero E6 and C6/36 cells, respectively. The highest titer of r2segMP12 was recorded with BHK-21 cells, reaching 1.3 ϫ 10 6 PFU/ml at 24 h p.i. (Fig. 4A to C) .
Protein synthesis in infected cells. In mammalian cells infected with rMP12, N and NSs were both detected by 12 h p.i., whereas in C6/36 cells, N was not detected until 18 h p.i. and NSs was only barely detectable by 24 h p.i. (Fig. 4D) . As expected, no NSs expression was detected at any time point in any cell line infected with r2segMP12 or rMP12-delNSs:eGFP-delNSm. The appearance of N protein was delayed in r2segMP12-infected cells but was similar in rMP12-delNSs:eGFP-delNSm compared to rMP12. The overall accumulation of N was slightly lower in all cells infected with the mutant viruses (Fig. 4D) .
Analysis of both glycoprotein and nucleocapsid expression in infected BHK-21 cells at 24 h p.i. (Fig. 5) revealed a significant decrease in the amount of Gn produced in r2segMP12-infected cells compared to that in rMP12-or rMP12-delNSs:eGFPdelNSm-infected cells. Comparing the intensity of the bands by using a luminescent image analyzer, it was estimated that the ratio of Gn to N was 19-fold lower in r2segMP12-infected cells.
Effect of MOI on virus titer.
It was noted that the titer of r2segMP12 in BHK-21 cells infected at an MOI of 1 (Fig. 4A) was lower than the titer of stock virus obtained directly from the rescue experiment. To investigate whether this was because the cells had been infected at different multiplicities, rMP12 and r2segMP12 viruses were inoculated onto BHK-21 cells at MOIs ranging from 0.0005 to 5 PFU/cell. At 72 h p.i., tissue culture supernatants were harvested and virus titers determined by plaque assay in BHK-21 cells (Fig. 6 ). There seemed to be little effect on the yield of rMP12 from cells infected at different MOIs, and titers ranged from 1.25 to 2.0 ϫ 10 8 PFU/ ml. In comparison, yields of r2segMP12 varied markedly. The virus grew to the highest titer (3.55 ϫ 10 7 PFU/ml) when the cells were infected with an MOI of 0.005 PFU/cell and the lowest titer (8.5 ϫ 10 4 PFU/ml) when the cells were infected at 5 PFU/cell. Rather strikingly, it seems that as the input multiplicity of r2segMP12 increased, the resulting titer recorded at 72 h p.i. decreased (Fig. 6) .
Serial passage of rMP12 and r2segMP12. rMP12 and r2segMP12 viruses were serially passaged in BHK-21 cells. At PFU/ml for r2segMP12 (Fig. 7B ).
Rescue and serial passage of r2segMP12 with an additional genome segment. To investigate whether the two-segmented r2segMP12 virus could carry an additional genome segment, we repeated the rescue experiment but also included a pTVT7-derived plasmid that expresses the eGFP ORF flanked by the exact RVFV M-segment UTRs (designated pTVT7-GMdel-MORF:eGFP). Some of the transfected BSR-T7/5 cells showed green autofluorescence by 3 days posttransfection (Fig.  8A ), indicating expression of the eGFP gene. Supernatant fluid was collected at 7 days posttransfection and passaged in BHK-21 cells. Supernatant from these cells was shown to contain virus that had a titer of 8 ϫ 10 6 PFU/ml. This virus, designated r2segMP12:MeGFPM, had a plaque phenotype slightly larger than that of the two-segmented virus r2segMP12 (Fig. 8B) .
To confirm that the virus had acquired a third segment containing the eGFP ORF, r2segMP12:MeGFPM was serially passaged 3 times in BHK-21 cells. On all occasions, cells in the monolayer expressed eGFP without any noticeable decrease in intensity between passage 1 and passage 3 (Fig. 8A) . The supernatant from each passage was used to infect BHK-21 cells, and total cell RNA was extracted. Northern blot analysis showed the same RNA species, as described above for r2segMP12, corresponding to the engineered S segment and subgenomic N mRNA [N(ϩ) probe] and subgenomic glycoprotein mRNA [Gn(ϩ) probe]. In addition, the GFP(Ϫ) probe, which hybridizes to the eGFP coding sequence, detected an RNA species approximately 1 kb in length (Fig. 8C) which corresponds in size (1,011 nt) to the sequence of the eGFP ORF flanked by the M-segment UTRs. Furthermore, this RNA was maintained by the virus upon serial passage, in agreement with the eGFP expression data shown in Fig. 8A . Thus, the presence of M-segment UTRs appeared sufficient to allow packaging and maintenance of an RNA segment that did not encode a virus protein.
DISCUSSION
The rationale for the work described above was based on previous reports demonstrating that the RVFV NSs protein is dispensable for virus replication and can be replaced with a foreign gene (7) . Thus, we asked whether the viral genome could be manipulated to accept the coding sequence for the viral glycoproteins inserted in the place of NSs. This would eliminate the need for the M RNA segment, thus generating a virus containing just two genomic segments. The precedent for an RNA virus with a two-segmented genome, with the smaller segment encoding the nucleocapsid and glycoprotein precursor proteins in an ambisense manner, already exists in nature with the arenaviruses (10) . Through the use of reverse genetics we were indeed able to create a modified RVFV MP12 virus containing a two-segmented genome that lacks both NSs and NSm proteins, called r2segMP12. For reasons unknown, we were unable to clone the complete M-segment ORF into the NSs locus in the plasmid pTVT7-GS. However, as previous work had shown that the NSm coding region could also be deleted from the M-segment ORF without affecting virus viability (18, 50), we cloned instead the sequence encoding the precursor to Gn and Gc. We also generated a three-segmented recombinant virus lacking both NSs and NSm proteins, called rMP12delNSs:eGFP-delNSm, for a more relevant comparison of the effect of condensing the genome into two segments. rMP12 and rMP12delNSs:eGFP-delNSm viruses grew to similar titers in mammalian cells that are deficient in their innate immune responses, such as Vero-E6 or BHK-21 cells (Fig. 4) , but in cultured mosquito cells, rMP12delNSs:eGFP-delNSm gave titers about 10-fold lower than rMP12. While this might suggest that either or both of the nonstructural proteins could play a role in infection of the arthropod vector, confirmation requires experimental infection of mosquitoes with mutant viruses. The two-segmented virus, however, was attenuated up to 1,000-fold compared to rMP12delNSs:eGFP-delNSm, as assessed by titers of released virus from mammalian or mosquito cells. Despite the attenuation of r2segMP12 in cell culture systems, the virus did grow to workable titers and was genetically stable when serially passaged (Fig. 7) .
It was also noted that the titer obtained for r2segMP12 in the BHK-21-infected single-step growth curve experiment was 100-fold lower than that measured in the virus stocks. We therefore tested the effect that the multiplicity of infection had upon the viral titer of both rMP12 and r2segMP12 in BHK-21 cells. The MOI of rMP12 used to infect BHK-21 cells had no bearing on the amount of virus produced over the 72-hour period, with all multiplicities of infection generating titers in the range of 10 8 PFU/ml (Fig. 6 ). This result has previously been observed for RVFV in both monolayer and suspended cell cultures, for which it was shown that the MOI had no effect on the titer of virus reached; it had an effect merely on the time taken to reach the peak titer in a given cell line (49) . When the titers of r2segMP12-infected cell supernatants were examined, there was a 1,000-fold decrease in titer between cells infected at 0.005 PFU/cell and 5 PFU/cell. This effect has been documented before for several members of the Bunyaviridae family, notably La Crosse virus (37) , Marituba virus (48) , and Bunyamwera virus (BUNV) (31) . For the last, under conditions of high multiplicity of infection in BHK-21 cells, autointerference was proposed to be associated with the production of defective virus particles (31) . It appears this phenomenon could explain the decrease in titer seen between high-MOI (single-step growth curve) and low-MOI (generation of working stock of virus) infections with r2segMP12 and that autointerference adversely affects r2segMP12 replication when BHK-21 cells are infected at high multiplicities. The possibility that r2segMP12 generates defective interfering particles more readily than rMP12 is under investigation.
The amount of N protein synthesized by r2segMP12 was apparently not the limiting factor to account for the lower titers, as this was not significantly different from that made by rMP12delNSs:eGFP-delNSm (Fig. 5) . However, there was a marked decrease in the amount of Gn produced in r2segMP12-infected cells compared to that in either rMP12-or rMP12delNSs:eGFP-delNSm-infected cells. Indeed, comparing the ratio of N to Gn, it was estimated that there was about 19-fold less Gn. There did not appear to be a deficiency in production of the glycoprotein subgenomic mRNA (Fig. 3) , and it could be that translation of the glycoprotein mRNA derived from the novel ambisense segment may be affected. The initiation codon of the Gn-Gc ORF in the hybrid segment is in a sequence context identical to that of the Gn-Gc ORF in the M segment of rMP12delNSs:eGFP-delNSm, and this is actually a more favorable context than that of the authentic M polyprotein ORF present in rMP12, suggesting that the reduced level of Gn is not due to inefficient initiation of translation. Also, both r2segMP12 and rMP12delNSs:eGFPdelNSm have the same Gn-Gc precursor coding sequence within their respective genomes, yet expression of Gn within rMP12delNSs:eGFP-delNSm-infected cells was not affected, indicating that the reduced Gn expression is not because of a defect in the cleavage of the Gn-Gc precursor. Further work is required to understand why less Gn is produced by r2segMP12.
Previous work on Uukuniemi phlebovirus (38, 39) and BUNV orthobunyavirus (42) indicated that the cytoplasmic tails of the viral glycoproteins, particularly that of Gn, were indispensable for viral replication. This was confirmed by Piper et al. (40) , who showed that the cytoplasmic tail of RVFV Gn recruits the L protein, nucleocapsid protein, and the genomic RNA into virions. They demonstrated that the first 30 amino acids of the sequence of the Gn-cytoplasmic tail are responsible for an interaction with the N protein, while the last 40 amino acids interact with the L protein, and these interactions mediate the efficient packaging of the RNP complex into the virion. Thus, a loss of Gn, as shown by r2segMP12, would severely affect production of progeny virions.
The packaging of the complete genetic complement of the segmented bunyavirus genome to generate infectious virus is poorly understood. A recent study of the mechanism of RVFV genome packaging (45), using a virus-like particle (VLP) production assay, suggested that direct or indirect interactions between the three RNA segments drive viral RNA copackaging to produce infectious virus. In particular, one region in the M segment 5Ј UTR was implicated as critical for copackaging. Two models of packaging were proposed. The first was that the M RNA acts as a "central regulator" for the packaging of S and L RNAs, with M having distinct sites of interaction with either L or S RNAs. It was shown that in the absence of the M segment the L RNA was poorly packaged into VLPs. The second model proposed that an interaction between M-and S-segment RNAs induces a conformational change in the S RNA, exposing putative RNA elements that can interact with the L segment and lead to the packaging of that RNA. Hence in the absence of M RNA, L RNA would not be efficiently packaged into VLPs or virions, as this putative conformational change would not be induced in the S RNA. Neither of these models seems compatible with the generation of an infectious RVFV with a two-segmented genome lacking the authentic M RNA segment: although r2segMP12 contains the M-segment coding region, the M-segment UTRs, including the critical region in the 5Ј UTR identified by Terasaki et al. (45) , are lacking. Furthermore, this was not merely an experimental artifact forced by the reverse genetics protocol, as r2segMP12 was stable over 10 serial passages, indicating that the two genome segments were packaged to generate infectious virions, without the necessity for the M-segment RNA and its putative interactions.
However, when an M-like RNA was also present in the transfected cells, it was readily packaged and, more significantly, maintained in the viral genome upon serial passage (Fig. 8) . These data suggest that the M RNA segment packaging signals reside in the UTRs, and although the M RNA packaging signals are not crucial for the production of infectious virus or efficient packaging of the other viral RNA segments, there appears to be a preference for the virus to package one each of the RNA segments. Studies with the prototype bunyavirus BUNV indicate that packaging signals probably just involve the UTR sequences and, unlike influenza virus genome segments (23), do not extend into the coding regions, but the packaging efficiency of individual segments varies (32) . However, the complete suite of L, M, and S packaging signals is not required, as a three-segment genome virus that lacked the L-segment UTRs was obtained by reverse genetics. This virus, which is attenuated in both cell culture and in mice, has authentic M and S segments and a third segment comprising the L ORF flanked by the BUNV M UTRs (34) . The plasticity of segmented genome packaging by negative-sense RNA viruses has been demonstrated by others with the creation of a three-segmented genome arenavirus (13) and influenza A viruses with seven (15) or nine (16) genome segments rather than eight. We show here that a recombinant RVFV can maintain a viral-like segment expressing a foreign gene without any selective pressure or apparent advantage to the virus. This system thus provides a valuable tool to facilitate the further exploration of genomic segment packaging in the context of a fully functional virus, rather than VLP assays as have been previously used (14, 20, 38) . It also provides the potential for RVFV to act as a vector for other foreign gene sequences.
There is an urgent need to develop new vaccines against RVF. The existing Smithburn vaccine is poorly immunogenic and can induce disease symptoms and abortion in pregnant animals (24) . Two candidate live-attenuated viruses, MP12 and Clone 13, are currently being evaluated in animal models (5, 6). More recently, Bird et al. (3) demonstrated that their NSsNSm doubly deleted virus, rZH501-⌬NSs:GFP-⌬NSm (based on the virulent RVFV strain ZH501), was attenuated in vivo and conferred protective immunity to a lethal challenge with virulent strains of RVFV. It seems likely that r2segMP12 described here would have similar properties. One of the reasons for creating the two-segmented RVFV was an attempt to generate a virus that could not undergo reassortment with a wildtype virus. This would alleviate safety concerns over the possible reversion to virulence of a live attenuated vaccine through reassortment with a cocirculating wild-type strain, as might happen during a rampant RVFV epidemic (41) , and similar concerns have been raised for live attenuated influenza virus vaccines (22) . The reassortment potential of r2segMP12 is under investigation. In addition, r2segMP12 has the unique potential to express another antigen and thus offers the possibility to create multivalent attenuated-virus vaccines.
